Cargando…

Omalizumab effectiveness in patients with a previously failed oral immunotherapy for severe milk allergy

BACKGROUND: Some studies addressed the issue of omalizumab (OML) effectiveness in children starting their first oral immunotherapy (OIT) attempt but no study investigated the possible role of OML in the setting of patients with persisting milk allergy after a failed OIT attempt. METHODS: Single‐cent...

Descripción completa

Detalles Bibliográficos
Autores principales:	Badina, Laura, Belluzzi, Beatrice, Contorno, Sarah, Bossini, Benedetta, Benelli, Elisa, Barbi, Egidio, Berti, Irene
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2021
Materias:	Short Reports
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8669684/ https://www.ncbi.nlm.nih.gov/pubmed/34623772 http://dx.doi.org/10.1002/iid3.542

Ejemplares similares

Life‐threatening anaphylaxis in children with cow's milk allergy during oral immunotherapy and after treatment failure
por: Badina, Laura, et al.
Publicado: (2022)

Risk factors for discontinuing oral immunotherapy in children with persistent cow milk allergy
por: Benelli, Elisa, et al.
Publicado: (2022)

Early introduction oral immunotherapy for IgE‐mediated cow's milk allergy: A follow‐up study confirms this approach as safe and appealing to parents
por: Badina, Laura, et al.
Publicado: (2021)

Young child with painful edema and purpura: a case report
por: Contorno, Sarah, et al.
Publicado: (2021)

Treatment of severe cow’s milk allergy with omalizumab in an adult
por: Klein, Benjamin, et al.
Publicado: (2023)

Oral immunotherapy combined with omalizumab for high–risk cow’s milk allergy: a randomized controlled trial
por: Takahashi, Masaya, et al.
Publicado: (2017)

Anaphylaxis in atypical cold urticaria: case report and review of literature
por: Benelli, Elisa, et al.
Publicado: (2018)

Author Correction: Oral immunotherapy combined with omalizumab for high–risk cow’s milk allergy: a randomized controlled trial
por: Takahashi, Masaya, et al.
Publicado: (2018)

Successful desensitization in a boy with severe cow’s milk allergy by a combination therapy using omalizumab and rush oral immunotherapy
por: Takahashi, Masaya, et al.
Publicado: (2015)

Successful management of severe cow's milk allergy with omalizumab treatment and CD-sens monitoring
por: Nilsson, Caroline, et al.
Publicado: (2014)

Immunotherapy for cow's milk allergy
por: Taniuchi, Shoichiro, et al.
Publicado: (2017)

Efficacy of omalizumab in reducing latex allergy
por: Aruanno, Arianna, et al.
Publicado: (2021)

Omalizumab for prevention of anaphylactic episodes in a patient with severe mosquito allergy
por: Meucci, Elisa, et al.
Publicado: (2021)

Changes in antigen-specific T cell number and function during oral desensitization in cow’s milk allergy enabled with omalizumab
por: Bedoret, D, et al.
Publicado: (2012)

Omalizumab as successful treatment option in severe peanut allergy
por: Dehlink, E, et al.
Publicado: (2013)

Oral Immunotherapy for Children with Cow’s Milk Allergy
por: Ogata, Mika, et al.
Publicado: (2021)

Omalizumab added to allergen immunotherapy increased the effect of therapy in patients with severe local allergic rhinitis
por: Bozek, Andrzej, et al.
Publicado: (2022)

Oral Immunotherapy for Children with Cow’s Milk Allergy: A Practical Approach
por: Tosca, Maria Angela, et al.
Publicado: (2022)

Dose-dependence of protection from systemic reactions to venom immunotherapy by omalizumab
por: Boni, Elisa, et al.
Publicado: (2016)

Oral immunotherapy for milk allergy: a systematic review
por: Yeung, Joanne P, et al.
Publicado: (2012)

A previously functional tetracycline-regulated transactivator fails to target gene expression to the bone
por: Schmidt, Eva, et al.
Publicado: (2011)

T2-Low Asthma: A Discussed but Still Orphan Disease
por: Peri, Francesca, et al.
Publicado: (2023)

Severe food allergy in children. Omalizumab as an alternative treatment to elimination diet
por: Pena Peloche, María, et al.
Publicado: (2011)

Allergy to Omalizumab: Lessons from a Reaction to the Coronavirus 2019 Vaccine
por: Matsumoto, Takeshi, et al.
Publicado: (2023)

Epigenetic features of FoxP3 in children with cow’s milk allergy
por: Paparo, Lorella, et al.
Publicado: (2016)

COVID-19 lockdown beneficial effects on lung function in a cohort of cystic fibrosis patients
por: Servidio, Alessia Giuseppina, et al.
Publicado: (2021)

75 Efficacy of Slow Oral Immunotherapy for Cow's Milk Allergy
por: Ogura, Kiyotake, et al.
Publicado: (2012)

Regular intake of cow’s milk with oral immunotherapy improves statures of children with milk allergies
por: Emura, Shigehito, et al.
Publicado: (2020)

Combination of omalizumab and bee venom immunotherapy: does it work?
por: Yılmaz, İnsu, et al.
Publicado: (2018)

Debates in Allergy Medicine: Oral immunotherapy shortens the duration of milk and egg allergy - the con argument
por: Loh, Wenyin, et al.
Publicado: (2018)

Omalizumab as a corticosteroid‐sparing agent in the treatment of bullous pemphigoid
por: Vassallo, Camilla, et al.
Publicado: (2022)

Xolair® (omalizumab) enrollment in a tertiary care allergy and asthma clinic in Canada
por: Cameron, Jodi, et al.
Publicado: (2014)

Efficacy of long-term treatment with omalizumab in a food and inhalant allergy patient
por: Nucera, Eleonora, et al.
Publicado: (2020)

Debates in Allergy Medicine: Does oral immunotherapy shorten the duration of milk and egg allergy? The pro argument
por: Pecora, Valentina, et al.
Publicado: (2018)

Role of specific IgE to β-lactoglobulin in the gastrointestinal phenotype of cow’s milk allergy
por: Poza-Guedes, Paloma, et al.
Publicado: (2016)

Treatment response with mepolizumab in severe eosinophilic asthma patients with previous omalizumab treatment
por: Magnan, A., et al.
Publicado: (2016)

Omalizumab in the prevention of anaphylaxis during immunotherapy: a case report
por: Stelmach, Iwona, et al.
Publicado: (2014)

270 Clinical Experience in Allergic Asthma Patients: Omalizumab with Immunotherapy
por: Yalcin, Arzu Didem, et al.
Publicado: (2012)

Successful treatment of a patient with adult food allergy and severe asthma using omalizumab
por: Nishie, Miyuki, et al.
Publicado: (2021)

Eight tips for the implementation of the first licenced peanut allergy oral immunotherapy into clinical practice
por: Portnoy, Jay, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_jtm89arpcdbfjle0q43k3ub5h8